Yuki Kagoya
Princess Margaret Cancer Centre
University Health Network
Yuki Kagoya has not added Biography.
If you are Yuki Kagoya and would like to personalize this page please email our Author Liaison for assistance.
High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis.
International journal of hematology Mar, 2010 | Pubmed ID: 20082159
Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
Annals of hematology Feb, 2011 | Pubmed ID: 20432036
Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar, 2011 | Pubmed ID: 20655388
A Case of Primary Bone Marrow B-Cell Non Hodgkin's Lymphoma with Severe Thrombocytopenia: Case Report and A Review of the Literature.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion Sep, 2010 | Pubmed ID: 21886395
Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases.
Clinical transplantation Sep-Oct, 2011 | Pubmed ID: 21919962
Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis.
Clinical transplantation Mar-Apr, 2012 | Pubmed ID: 22507357
Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis.
Leukemia research Aug, 2012 | Pubmed ID: 22579366
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
The Journal of clinical investigation Feb, 2014 | Pubmed ID: 24382349
Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemia.
British journal of haematology May, 2014 | Pubmed ID: 24401018
Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16.
Cancer science May, 2014 | Pubmed ID: 24612037
Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma.
British journal of haematology Sep, 2014 | Pubmed ID: 24749697
JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2.
Blood Nov, 2014 | Pubmed ID: 25217696
Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors.
Leukemia & lymphoma Jun, 2015 | Pubmed ID: 25267182
Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Blood Dec, 2014 | Pubmed ID: 25298035
[NF-κB activity in myeloid leukemia stem cells].
[Rinsho ketsueki] The Japanese journal of clinical hematology Apr, 2015 | Pubmed ID: 25971268
Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Experimental hematology Oct, 2015 | Pubmed ID: 26021490
CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells.
Scientific reports Mar, 2016 | Pubmed ID: 27030642
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models.
The Journal of clinical investigation Sep, 2016 | Pubmed ID: 27548527
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved